|
|
|
|
|
|
|
|
Background: Previously, small studies have found that BRCA1 and BRCA2
breast tumors differ in their pathology. Analysis of larger datasets of
mutation carriers should allow further tumor characterization.
Methods: We used data from 4,325 BRCA1 and 2,568 BRCA2 mutation carriers to analyze the pathology of invasive breast, ovarian, and contralateral breast cancers.
There were no significant differences in ovarian cancer morphology between BRCA1 and BRCA2 carriers (serous: 67%; mucinous: 1%; endometrioid: 12%; clear-cell: 2%).
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.